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measurements in each 6 hour segment. Mean slopes for each segment are
presented.
We conclude that myocardial infarction has an important influence on dy-
namic OT behaviour. Slopes during the day, the evening an the night are
steeper compared to slopes in normal individuals.
Beta-blocker therapy results in a significant decrease of OT-slope after my-
ocardial infarction and tends to normalize the rate dependent changes of the
OT interval.
15% as haVing severe CAD. In this asymptomatic population, 228 En's and
7 coronary angiograms were performed in order to identify 1 individual with
severe CAD. Using Medicare reimbursement of $70 for En and $1500 for
angiography, the cost of screening per case of severe CAD identified would
be $26,460. Based on previously published data on survival with surgical and
medical therapy in patients with severe CAD, we estimate a cost of $120,000
to $180,000 per year of life saved with this screening approach. Conclusion:
This low yield suggests that screening asymptomatic individuals with En
may be costly and of little clinical value compared to other screening ap-
proaches.
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Cardiovascular Risk Factors Levels and Changes
Following Lifestyle Intervention In Families: The
British Family Heart Study
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1801-61 A New Noninvasive Test to Predict Inducible
Ventricular Tachycardia In Patients with Unexplained
Syncope: QT Dispersion
Leigh A. Hutchinson. Fidela Moreno, Frederick A. Ehlert. Jonathan S. Steinberg St.
Luke's-Roosevelt Hospital Center and Columbia University, New York, NY; WS Hospital,
Salt Lake City, ur
Regional disparities in ventricular repolarization are known to promote reen-
trant ventricular arrhythmias; recent work suggests that this may be as-
sessed noninvasively using OT/JT dispersion on the surface ECG. However,
very little data is available on its clinical use. We studied pts with unexplained
syncope to determine if inducible VT could be predicted by OT dispersion
(OTd, defined as OTmax-OTmin), OT standard deviation (OTstd), and equiv-
alent JT intervals. Values were also corrected using Bazetl's formula. We
enrolled 38 pts (22 M, age = 59 ± 18 yrs, 29% prior MI) who underwent pro-
grammed electrical stimulation (PES). Standard ECGs were recorded prior
to PES and analyzed by a computerized analyzer/digitizer. Results: Of the 38
pts, 9 (24%) had inducible sustained VT and 29 pts did not.
VT
NoVT
p value
Old
59 ± 18
46 ± 14
0.03
OTstd
18 ± 5
14± 4
002
JTd
63 ± 21
51 ± 12
008
JTstd
19 ± 4
15 ± 5
003
David Wood, Stephen Pyke, Ann-Louise Kinmonth, Simon Thompson, British
Family Heart Study Group. Department of Clinical Epidemiology, National Heart and
Lung Institute. London, UK
2373 families were recruited to a national randomised controlled trial of car-
diovascular screening and lifestyle intervention in 26 general practices in 13
towns across Britain. 2054 (87%) comprised both a male and female partner
and amongst these 1477 (72%) were represented at screening by both part-
ners. There was a significant association between reported cigarette smok-
ing habits in partners (odds ratio 6.1 95% CI4.6, 8.0) at baseline. Where both
partners were initially smokers, men were 5 times and women were 10 times
(p < 0.05) more likely to have quit where their partner had also quit. Body
mass index (BMI) measurements were correlated (r = 0.21, p < 0.0001) at
baseline and one year changes in BMI in partners were also significantly cor-
related (r = 0.20, p < 0.0001). Similar results were found for systolic blood
pressure, blood cholesterol and blood glucose cross-sectionally (r = 0.14,
0.10, 0.13 respectively, p < 0.0005) and longitudinally (r = 0.14, 0.24, 0.19
respectively, p < 0.0001). Whilst the cross sectional inter-partner relation-
ships are weak the longitudinal results demonstrate the scope for cardio-
vascular intervention programmes to capitalize on the tendency of partners
to change together. Men and women most able to improve their risk factor
profile over a one year period tend to have partners who also improve sub-
stantially. Therefore, for lifestyle intervention programmes in middle aged
men and women, targeting a couple together rather than as individual pa-
tients may result in a greater reduction in cardiovascular risk factors through
mutual reinforcement of lifestyle changes.
Standard ORS, OT and OTc, and corrected dispersion intervals were not
significantly different between pts with and without inducible VT.
Conclusion: Confirming the relationship of dispersion of ventricular repo-
larization and ventricular reentry, several ECG parameters of dispersion were
associated with inducible VT in patients with unexplained syncope. OT dis-
persion is a novel and noninvasive measure of risk of VT.
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1802-1 I Clinical Value and Cost of Screening Exercise
Treadmill Testing In Asymptomatic Individuals
Louise Pilote, Michael S. Lauer, Fredric Pashkow. Thomas H. Marwick. James
D. Thomas Cleveland Clinic Foundation, Cleveland, OH
Background: Exercise treadmill testing (En) is frequently performed to
screen for coronary artery disease (CAD) in asymptomatic individuals; how-
ever, its clinical value is questionable. Methods: To evaluate the clinical value
of ETT, we examined a cohort of asymptomatic individuals undergoing En
at the Cleveland Clinic between September 1990 and December 1993. En
was abnormal if it exhibited any of the following; a 1 mm ST-T elevation or
depression, a drop in blood pressure ,=:10 mmHg, chest pain or failure to
reach a target heart rate. Any CAD was defined by at least 1 coronary seg-
ment with ,=:50% stenosis. Severe CAD was defined by the following: 1) left
main coronary artery with ,=:50% stenosis, 2) 3 vessels with ,=:70% steno-
sis or 3) proximal left anterior descending artery and 2 vessels with ,=:70%
stenosis. Results: During this period, 4335 En's were performed in individ-
uals with no cardiac symptoms. The average age was 53, 89% were male
and 16% had at least one cardiac risk factor. Fifteen percent exhibited an
abnormal En. Among those with an abnormal ETT, 14% underwent coro-
nary angiography while among those with a negative En, 1% underwent
angiography. Coronary angiography identified 56% as having any CAD and
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\802-31 Treatment of Ventricular Arrhythmias After the
Cardiac Arrhythmia Suppression Trial (CAST): A
Survey of US Physicians
Yves Rosenberg. Eleanor Schron, Mario Stylianou, Albert Parker. National Heart,
Lung, and Blood InsMute, Bethesda, MD
To determine how US physicians treat patients with asymptomatic ventricu-
lar arrhythmias we conducted in fall 1992, after the publication of all CAST
results, a telephone survey of a randomly selected sample of 1072 American
generalists (G) and cardiologists (C). as part of a survey designed to study
how the results of three major cardiovascular clinical trials have influenced
medical practice.
730 physicians reported treating patients with ventricular arrhythmias. The
response rate was 63% (G: 65.3%, C: 60.9%). 44.2% of G, but only 22.1 %
of C would routinely use an antiarrhythmic drug (MD) or device to treat a
patient presenting ventricular premature depolarizations (VPD) who had a
myocardial infarction (MI) in the past six months (P < 0.001). 68.2% of G
and 40% of C would treat the same patient if he presented asymptomatic
nonsustained ventricular tachycardia (NSVT), p < 0.001. For the former con-
dition, the first choice drug would be a tl-blocker (G = 53.5%, C = 74%,p <
0.002). but 28.3% of G and 23.5% of C would use a class I MD (with <1 %
using a class IC).
36.9% of G and 16.1 % of C would treat a patient with coronary heart dis-
ease and an ejection fraction <40% presenting asymptomatic VPD, 66.2%
of G and 39.6% of Cwould treat asymptomatic NSVT (p < 0.001). For asymp-
tomatic VPD, the first choice drug is a Class I MD (G = 46.4%, C = 47.2%);
27.4% of G and 44.4% of C would prescribe a tl-blocker; 11.9% of G but no
C would prescribe a calcium-blocker. For the physicians treating NSVT, the
first choice drug is:
Class I Class II Class III Class IV Other Other
IA IB IC AAD
G(n ~ 145) 49% 0% 0.7% 172% 0% 9.7% 4.8% 11.7%
C(n = 91) 51.7% 12.1% 1.1% 29.7% 2.2% 2.2% 0% 1.1%
Total 50% 8.9% 0.8% 22% 0.8% 6.8% 3% 7.6%
